Close Menu

PALM SPRINGS, CALIFORNIA (GenomeWeb) – The 2016 edition of the Mass Spectrometry: Applications to the Clinical Lab US (MSACL) conference highlighted the continued challenges of aligning the technology with the broader agenda of the diagnostics field.

The mass spec-based diagnostics field is like a water balloon; it is set to be squeezed on one end by impending regulation of laboratory-developed tests, but also to expand as matrix-assisted laser desorption/ionization (MALDI) mass spec platforms gain greater adoption in the clinical market.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.